Union biometrics유니온바이오메트릭스
203450 · KOSDAQ · ₩203450 · 유니온바이오메트릭스
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩484
vs the current price (₩2,590)
- Enterprise value
- ₩6.4B
- Equity value
- ₩6.8B
- WACC
- 6.9%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 81% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩2,590, the model needs an operating margin of 5.8% every year (it uses 2.2%).
- 100% of the last 12 months' net profit came from outside operations (stakes in other companies, interest, one-offs). The model adds those stakes at book value but doesn't project that income.
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
- Today's P/E is 29.6× against a typical 16.1× over the last 10 years.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- —
- Base
- ₩484
- −81.3%
- Bull
- ₩2,220
- −14.3%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (2.2%).
Revenue growth
- 3.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (3.5% a year, annual reports), fading to 3% by year 5.
- 3.4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (3.5% a year, annual reports), fading to 3% by year 5.
- 3.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (3.5% a year, annual reports), fading to 3% by year 5.
- 3.1%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (3.5% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (3.5% a year, annual reports), fading to 3% by year 5.
Business
- 2.2%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 1.7%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 2.2%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 35.4%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.03%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-27.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.18, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.53%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩52B
- Net debt (borrowings and leases − cash and deposits)
- ₩5B
- + Stakes and investments
- ₩5.5B
- Associates, long-term financial assets and deposits (book value)
- Shares
- 14,079,007
- Share price
- ₩2,590
- Market cap
- ₩36B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩51B | ₩57B | ₩51B | ₩54B | ₩55B | ₩57B | ₩59B | ₩61B |
| Growth | 11.1% | 10.4% | −9.6% | 3.5% | 3.4% | 3.3% | 3.1% | 3.0% |
| EBIT | ₩1.6B | ₩2.8B | ₩1B | ₩1.2B | ₩1.2B | ₩1.3B | ₩1.3B | ₩1.3B |
| EBIT margin | 3.1% | 5.0% | 2.0% | 2.2% | 2.2% | 2.2% | 2.2% | 2.2% |
| After-tax EBIT | ₩1.1B | ₩2.1B | ₩740M | ₩856M | ₩885M | ₩914M | ₩943M | ₩971M |
| + Depreciation | — | — | — | ₩912M | ₩943M | ₩975M | ₩1B | ₩1B |
| − Capital spending | ₩2B | ₩748M | ₩686M | ₩1.2B | ₩1.2B | ₩1.3B | ₩1.3B | ₩1.3B |
| − Working capital | −₩10B | −₩4.9B | ₩14B | ₩642M | ₩646M | ₩648M | ₩629M | ₩628M |
| Free cash flow | — | — | — | −₩55M | −₩38M | −₩21M | ₩18M | ₩39M |
| Discount factor | — | — | — | 0.935 | 0.875 | 0.818 | 0.765 | 0.715 |
| Present value | — | — | — | −₩51M | −₩33M | −₩17M | ₩14M | ₩28M |
Terminal value ₩9B, worth ₩6.5B today: 101% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩2,871 a share)Now 0.90× | ₩2,7690.96× | ₩3,2291.12× | ₩4,1251.44× |
| Price / earnings (last 12 months: ₩88 a share)Now 29.6× | ₩7188.20× | ₩1,41216.1× | ₩2,53228.9× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 5.9% | ₩736 | ₩689 | ₩628 | ₩548 | ₩439 |
| 6.4% | ₩656 | ₩608 | ₩548 | ₩471 | ₩370 |
| 6.9% | ₩589 | ₩542 | ₩484 | ₩411 | ₩319 |
| 7.4% | ₩533 | ₩487 | ₩432 | ₩364 | ₩280 |
| 7.9% | ₩486 | ₩441 | ₩389 | ₩326 | ₩249 |
Now (TTM)
- Market cap
- ₩36B
- Enterprise value
- ₩42B
- P/E
- 29.6×
- P/B
- 0.9×
- P/S
- 0.7×
- EV/EBITDA
- —
- Dividend yield
- 3.5%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩3,115 | ₩2,710 | ₩3,340 | ₩3,085 | ₩3,910 |
| Market cap | ₩44B | ₩38B | ₩47B | ₩43B | ₩55B |
| P/E | 21.8× | 7.7× | 15.3× | 20.2× | 23.4× |
| P/B | 1.1× | 0.9× | 1.2× | 1.2× | 1.5× |
| P/S | 0.9× | 0.7× | 0.9× | 0.9× | 1.4× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 2.9% | 2.6% | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Union biometrics | 29.6× | 0.9× | 0.7× | — | 3.5% |
| Samsung Electronics | 8.7× | 2.3× | 2.7× | — | 0.8% |
| LG Electronics | 24.7× | 1.0× | 0.3× | — | 0.9% |
| Hanwha Vision | 16.4× | 2.1× | 1.0× | — | 0.0% |
| RFHIC | 37.6× | 3.4× | 6.1× | — | 0.9% |
| KMW | — | 4.9× | 8.1× | — | 0.0% |
| Intellian Technologies | 12.9× | 2.0× | 1.6× | — | 0.4% |
| Similar companies (median) | 16.4× | 2.2× | 2.1× | — | 0.6% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Union biometrics / 유니온바이오메트릭스 / 203450 / KRX:203450
Source: KRX statistical information